Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03311191 · ClinicalTrials.gov registry record
Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 11
- Enrollment target
NCT03311191: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT03311191 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03311191 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This research study aims to determine if there are differences in oxygen consumption between chronically sun exposed and less sun exposed skin. This study uses a new imaging device that can detection oxygenation properties skin in a non-invasive manner.
Primary Outcome
The skin's partial pressure of oxygen and oxygen consumption rate is measured at 4 different locations on the subjects arms using the oxygen sensing device, where it is expected that that difference between more sun exposed regions and less sun exposed regions will be greater in the population of older adults.
Interventions
- DEVICE Measurement of skin oxygenation and oxygen consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2019-06-06 |
Why NCT03311191 stopped before completion
NCT03311191 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Measurement of skin oxygenation and oxygen consumption is the first listed.
NCT03311191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03311191 about?
NCT03311191 is a clinical study titled "Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin". This research study aims to determine if there are differences in oxygen consumption between chronically sun exposed and less sun exposed skin. This study uses a new imaging device that can detection oxygenation properties skin in a non-invasive manner.
What is the current status of trial NCT03311191?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2017-07-17. Estimated completion is 2019-06-06.
What interventions are being tested in trial NCT03311191?
The interventions under investigation include: Measurement of skin oxygenation and oxygen consumption (DEVICE).
Who is sponsoring clinical trial NCT03311191?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI